Art Community

CELECOR COMPLETES SUBMISSION OF FDA NEW DRUG APPLICATION FOR INVESTIGATIONAL HEART-ATTACK DRUG

Filing follows release of positive Phase 3 study results for zalunfiban (DisaggproTM);company also appoints Chief Commercial OfficerDEL MAR, Calif., June 24, 2026 /PRNewswire/ — CeleCor Therapeutics has submitted the final section of its New Drug Application for the company's…

Read the full release →

News provided by PR Newswire.

Ethan Parker

Ethan Parker covers stories about community life, personal well-being, local initiatives, lifestyle trends, and the people working to create stronger communities. His writing looks for the human element behind larger developments, focusing on practical ideas and meaningful stories. Ethan brings an approachable perspective to subjects involving everyday life, community participation, creativity, and social connection.

View all posts